Career Moves: Peter Hutt, ‘Father of Modern Food and Drug Law,’ Joins EVŌQ Nano Board
TECHNOLOGY EVŌQ, a Salt Lake City-based nanoscience company offering an antimicrobial nanoparticle platform across healthcare, textiles and beyond, has appointed Peter Barton Hutt to its board of directors. Hutt is widely recognized as the “Father of Modern Food and Drug Law” and has over six decades of food and drug law expertise. He currently is a […]
Why Tony Robbins invested in EVŌQ Nano
The global fight against antibiotic-resistant bacteria has a new ally. The global fight against antibiotic-resistant bacteria has a new ally. Business strategist Tony Robbins has stepped in to help battle the world’s worst superbugs by investing in EVŌQ Nano. What drew Robbins’ attention? Our novel nanoparticle, EVQ-218, has the ability to kill bacteria from the inside without triggering […]
EVŌQ Nano Receives Funding from Tony Robbins
Nanoscience company EVŌQ Nano announced a strategic investment from entrepreneur Tony Robbins. Nanoparticles for Health and Textiles The company has been developing an inhaled therapeutic using the nanoparticle EVQ-218 that is used to treat pulmonary bacterial infections for cystic fibrosis patients. EVŌQ Nano also plans to create products or medical devices called EVŌQ MedTech. This […]
Ondine accelerates pivotal antimicrobial trial after $11m financing
Ondine’s Phase III trial will investigate its Steriwave system for nasal photodisinfection before surgery. Ondine Biomedical will initiate a Phase III trial of its light-activated antimicrobial technology to reduce healthcare-associated infections (HAIs) early after a $11m fundraising boost. The Canadian biotech said it experienced strong support from existing investors in the latest funding round and […]
Ondine accelerates pivotal antimicrobial trial after $11m financing
Ondine’s Phase III trial will investigate its Steriwave system for nasal photodisinfection before surgery. Ondine Biomedical will initiate a Phase III trial of its light-activated antimicrobial technology to reduce healthcare-associated infections (HAIs) early after a $11m fundraising boost. The Canadian biotech said it experienced strong support from existing investors in the latest funding round and […]
On the front lines of the superbug war, new treatments can’t arrive soon enough
As antimicrobial resistance rises, researchers are running out of time to fight each new wave of superbugs. And the funding isn’t enough. The superbugs are winning the war. Even as an arsenal of new strategies lights the path forward, researchers are still falling behind as almost 5 million deaths mount each year. In the “losing battle” against antimicrobial-resistant […]
EVQ-218: A Promising Candidate for Tackling Superbugs Without Triggering Antimicrobial Resistance
As the United Nations (UN) prepares to address the escalating threat of antimicrobial resistance, EVŌQ Nano is helping raise awareness through an educational infographic depicting a common trigger of antimicrobial resistance and highlighting EVQ-218’s novel mechanism of action. Antimicrobial resistance (AMR) — considered a top 10 global health threat — occurs when bacteria mutate to outsmart […]
Silver nanoparticle destroys bacteria from the inside
New data indicates EVŌQ Nano’s nanoparticle EVQ-218 could combat the world’s worst superbugs without triggering antimicrobial resistance (AMR). Bacteria’s ability to form biofilms is a key factor in their resistance to antibiotics. Biofilms are protective layers that shield bacteria from therapeutic interventions and the body’s immune system, especially in conditions like cystic fibrosis where infections become […]
Salt Lake City Firm Hopes To Strike Gold With New Form Of Silver
As the World Health Organization (WHO) calls for advancements to combat serious infections, one American firm is raising awareness about its work on nanoparticles. As the world faces an increasing threat from antimicrobial resistance (AMR), the WHO is urging life science firms to find ways to replace ineffective treatments. Based in Utah state capital Salt […]
EVŌQ Nano’s Silver Nanoparticle, EVQ-218, Demonstrates Effectiveness Against WHO’s Top Six Antibiotic-Resistant Bacteria
A novel nanoparticle, EVQ-218, developed by EVŌQ Nano, has been shown to be effective against the WHO’s top six antibiotic-resistant strains of bacteria that cause infections that threaten human health, according to a recent announcement from the Salt Lake City-based nanoscience company. Last month, the World Health Organization (WHO) called for urgent innovation in antibacterial […]